HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1101	7555 Strong MJ Neurofilament metabolism in sporadic amyotrophic lateral sclerosis JOURNAL OF THE NEUROLOGICAL SCIENCES. 1999 OCT 31; 169 (1-2): 170-177	16	33	40	119
1102	8182 Yasuda M, Takamatsu J, D'Souza I, Crowther RA, Kawamata T, et al. A novel mutation at position+12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto) ANNALS OF NEUROLOGY. 2000 APR; 47 (4): 422-429	62	65	40	46
1103	8365 Crowther RA, Goedert M Abnormal tau-containing filaments in neurodegenerative diseases JOURNAL OF STRUCTURAL BIOLOGY. 2000 JUN; 130 (2-3): 271-279	40	58	40	59
1104	8633 Galvin JE, Nakamura M, McIntosh TK, Saatman KE, Sampathu D, et al. Neurofilament-rich intraneuronal inclusions exacerbate neurodegenerative sequelae of brain trauma in NFH/LacZ transgenic mice EXPERIMENTAL NEUROLOGY. 2000 SEP; 165 (1): 77-89	11	11	40	75
1105	8876 Sanchez I, Hassinger L, Sihag RK, Cleveland DW, Mohan P, et al. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: Selective role of site-specific phosphorylation JOURNAL OF CELL BIOLOGY. 2000 NOV 27; 151 (5): 1013-1024	34	72	40	62
1106	8884 Bajaj NPS Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS. 2000 DEC; 1 (5): 319-327	1	10	40	109
1107	9754 Blennow K, Vanmechelen E, Hampel H CSF total tau, a beta 42 and phosphorylated tau protein as biomarkers for Alzheimer's disease MOLECULAR NEUROBIOLOGY. 2001 AUG-DEC; 24 (1-3): 87-97	46	82	40	73
1108	10185 von Bergen M, Barghorn S, Li L, Marx A, Biernat J, et al. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 DEC 21; 276 (51): 48165-48174	80	109	40	67
1109	10520 Cohlberg JA, Li J, Uversky VN, Fink AL Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro BIOCHEMISTRY. 2002 FEB 5; 41 (5): 1502-1511	46	102	40	71
1110	11217 Zhu XW, Lee HG, Raina AK, Perry G, Smith MA The role of mitogen-activated protein kinase pathways in Alzheimer's disease NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 270-281	42	120	40	143
#	Date / Author / Journal	LCS	GCS	LCR	CR
1111	11251 Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, et al. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC) ACTA NEUROPATHOLOGICA. 2002 OCT; 104 (4): 333-341	7	14	40	57
1112	11443 Biernat J, Wu YZ, Timm T, Zheng-Fischhofer QY, Mandelkow E, et al. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity MOLECULAR BIOLOGY OF THE CELL. 2002 NOV; 13 (11): 4013-4028	35	100	40	91
1113	11619 Barghorn S, Mandelkow E Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments BIOCHEMISTRY. 2002 DEC 17; 41 (50): 14885-14896	72	99	40	57
1114	12088 Munishkina LA, Phelan C, Uversky VN, Fink AL Conformational behavior and aggregation of alpha-synuclein in organic solvents: Modeling the effects of membranes BIOCHEMISTRY. 2003 MAR 11; 42 (9): 2720-2730	48	98	40	107
1115	12896 Delacourte A, Sergeant N, Buee L In vitro models of age-related neurodegenerative disorders EXPERIMENTAL GERONTOLOGY. 2003 NOV-DEC; 38 (11-12): 1309-1317	2	7	40	59
1116	12929 Ninkina N, Papachroni K, Robertson DC, Schmidt O, Delaney L, et al. Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene MOLECULAR AND CELLULAR BIOLOGY. 2003 NOV; 23 (22): 8233-8245	14	23	40	58
1117	13069 Rao MV, Campbell J, Yuan AD, Kumar A, Gotow T, et al. The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate JOURNAL OF CELL BIOLOGY. 2003 DEC 8; 163 (5): 1021-1031	21	42	40	88
1118	13187 Windisch M, Hutter-Paier B, Schreiner E, Wronski R beta-synuclein-derived peptides with neuroprotective activity - An alternative treatment of neurodegenerative disorders? JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (1): 155-165	8	10	40	52
1119	14121 Nakashima H, Ishihara T, Yokota O, Terada S, Trojanowski JQ, et al. Effects of alpha-tocopherol on an animal model of tauopathies FREE RADICAL BIOLOGY AND MEDICINE. 2004 JUL 15; 37 (2): 176-186	24	24	40	88
1120	14271 Albani D, Peverelli E, Rametta R, Batelli S, Veschini L, et al. Protective effect of TAT-delivered alpha-synuclein: relevance of the C- terminal domain and involvement of HSP70 FASEB JOURNAL. 2004 SEP; 18 (12): 1713-+	28	41	40	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
1121	14384 von Coelln R, Dawson VL, Dawson TM Parkin-associated Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 175-184	28	61	40	75
1122	14684 Ross CA, Pickart CM The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases TRENDS IN CELL BIOLOGY. 2004 DEC; 14 (12): 703-711	26	103	40	93
1123	14721 Morris HR Genetics of Parkinson's disease ANNALS OF MEDICINE. 2005; 37 (2): 86-96	12	32	40	101
1124	14950 Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress HUMAN MOLECULAR GENETICS. 2005 JAN 1; 14 (1): 71-84	54	99	40	67
1125	14957 von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E Tau aggregation is driven by a transition from random coil to beta sheet structure BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 158-166	29	51	40	63
1126	15058 Mikolaenko I, Pletnikova O, Kawas CH, O'Brien R, Resnick SM, et al. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA) JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 156-162	27	39	40	78
1127	15216 Liu Q, Smith MA, Avila J, DeBernardis J, Kansal M, et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations FREE RADICAL BIOLOGY AND MEDICINE. 2005 MAR 15; 38 (6): 746-754	22	41	40	72
1128	15366 Braak H, Rub U, Steur ENHJ, Del Tredici K, de Vos RAI Cognitive status correlates with neuropathologic stage in Parkinson disease NEUROLOGY. 2005 APR 26; 64 (8): 1404-1410	73	123	40	94
1129	17260 Vartiainen S, Pehkonen P, Lakso M, Nass R, Wong G Identification of gene expression changes in transgenic C-elegans overexpressing human alpha-synuclein NEUROBIOLOGY OF DISEASE. 2006 JUN; 22 (3): 477-486	11	19	40	66
1130	17392 Kubo SI, Hattori N, Mizuno Y Recessive Parkinson's disease MOVEMENT DISORDERS. 2006 JUL; 21 (7): 885-893	3	14	40	126
#	Date / Author / Journal	LCS	GCS	LCR	CR
1131	17563 Fleming SM, Chesselet MF Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism BEHAVIOURAL PHARMACOLOGY. 2006 SEP; 17 (5-6): 383-391	5	16	40	88
1132	17714 Lin H, Schlaepfer WW Role of neurofilament aggregation in motor neuron disease ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 399-406	2	4	40	86
1133	17874 Masters CL, Beyreuther K Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A beta amyloid pathway BRAIN. 2006 NOV; 129: 2823-2839	12	42	40	194
1134	18051 Braak H, Bohl JR, Muller CM, Rub U, de Vos RAI, et al. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered MOVEMENT DISORDERS. 2006 DEC; 21 (12): 2042-2051	42	88	40	111
1135	18174 Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D Treatment of dementia in Parkinsonian syndromes with cholinesterase inhibitors DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007; 23 (6): 351-367	1	2	40	176
1136	18241 Rankin CA, Sun Q, Gamblin TC Tau phosphorylation by GSK-3 beta promotes tangle-like filament morphology MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 12	5	13	40	53
1137	18289 Farkas O, Povlishock JT Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 43-59	5	23	40	98
1138	18424 Chu YP, Kordower JH Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? NEUROBIOLOGY OF DISEASE. 2007 JAN; 25 (1): 134-149	43	68	40	73
1139	18850 Shaw LM, Korecka M, Clark CM, Lee VMY, Trojanowski JQ Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics NATURE REVIEWS DRUG DISCOVERY. 2007 APR; 6 (4): 295-303	88	88	40	93
1140	18858 Kuhn M, Haebig K, Bonin M, Ninkina N, Buchman VL, et al. Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein NEUROGENETICS. 2007 APR; 8 (2): 71-81	5	10	40	67
#	Date / Author / Journal	LCS	GCS	LCR	CR
1141	19411 Ferman TJ, Boeve BF Dementia with Lewy bodies NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 741-+	6	8	40	191
1142	19500 Rademakers R, Hutton M The genetics of frontotemporal lobar degeneration CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2007 SEP; 7 (5): 434-442	14	14	40	73
1143	20924 Matus S, Lisbona F, Torres M, Leon C, Thielen P, et al. The stress rheostat: An interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration CURRENT MOLECULAR MEDICINE. 2008 MAY; 8 (3): 157-172	8	31	40	173
1144	20939 Lim J, Balastik M, Lee TH, Nakamura K, Liou YC, et al. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy JOURNAL OF CLINICAL INVESTIGATION. 2008 MAY; 118 (5): 1877-1889	7	12	40	72
1145	21256 Moore DJ, Dawson TM Value of genetic models in understanding the cause and mechanisms of Parkinson's disease CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2008 JUL; 8 (4): 288-296	5	10	40	55
1146	21688 Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, et al. Direct quantification of CSF alpha-synuclein by ELISA and first cross- sectional study in patients with neurodegeneration EXPERIMENTAL NEUROLOGY. 2008 OCT; 213 (2): 315-325	28	36	40	70
1147	21934 Luk KC, Mills IP, Trojanowski JQ, Lee VMY Interactions between Hsp70 and the Hydrophobic Core of alpha-Synuclein Inhibit Fibril Assembly BIOCHEMISTRY. 2008 NOV 25; 47 (47): 12614-12625	14	14	40	56
1148	22420 Kalinderi K, Fidani L, Bostantjopoulou S From 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome PARKINSONISM & RELATED DISORDERS. 2009 JAN; 15 (1): 2-5	0	1	40	50
1149	22578 Wijesekera LC, Leigh PN Amyotrophic lateral sclerosis ORPHANET JOURNAL OF RARE DISEASES. 2009 FEB 3; 4: Art. No. 3	10	34	40	299
1150	22804 Nakamura T, Lipton SA Cell death: protein misfolding and neurodegenerative diseases APOPTOSIS. 2009 APR; 14 (4): 455-468	5	31	40	174
#	Date / Author / Journal	LCS	GCS	LCR	CR
1151	23855 Su XM, Federoff HJ, Maguire-Zeiss KA Mutant alpha-Synuclein Overexpression Mediates Early Proinflammatory Activity NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 238-254	7	7	40	88
1152	24093 Pirkevi C, Lesage S, Brice A, Basak AN From Genes to Proteins in Mendelian Parkinson's Disease: An Overview ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY. 2009 DEC; 292 (12): 1893-1901	0	1	40	110
1153	24468 Dawson TM, Dawson VL The Role of Parkin in Familial and Sporadic Parkinson's Disease MOVEMENT DISORDERS. 2010; 25 (3): S32-S39	3	7	40	84
1154	24651 Szaro BG, Strong MJ Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease TRENDS IN NEUROSCIENCES. 2010 JAN; 33 (1): 27-37	0	3	40	109
1155	24682 Waxman EA, Emmer KL, Giasson BI Residue Glu83 plays a major role in negatively regulating alpha- synuclein amyloid formation BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010 JAN 15; 391 (3): 1415-1420	1	1	40	58
1156	24747 Rozga M, Bal W The Cu(II)/A beta/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity CHEMICAL RESEARCH IN TOXICOLOGY. 2010 FEB; 23 (2): 298-308	1	2	40	164
1157	24936 Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, et al. Novel therapeutics for Alzheimer's disease: An update CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 MAR; 13 (2): 235-246	1	5	40	166
1158	25126 Pienaar IS, Dexter DT, Burkhard PR Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis EXPERT REVIEW OF PROTEOMICS. 2010 APR; 7 (2): 205-226	0	1	40	212
1159	25185 Murray LM, Talbot K, Gillingwater TH Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 133-156	1	6	40	199
1160	25381 Di Giovanni S, Eleuteri S, Paleologou KE, Yin GW, Zweckstetter M, et al. Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of alpha-Synuclein and beta-Amyloid and Protect against Amyloid-induced Toxicity JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 MAY 14; 285 (20): 14941-14954	2	2	40	92
#	Date / Author / Journal	LCS	GCS	LCR	CR
1161	25639 Jiang ML, Porat-Shliom Y, Pei Z, Cheng Y, Xiang L, et al. Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism JOURNAL OF NEUROCHEMISTRY. 2010 JUL; 114 (2): 419-429	0	0	40	59
1162	25752 Wang YP, Garg S, Mandelkow EM, Mandelkow E Proteolytic processing of tau BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 955-961	0	1	40	78
1163	26047 Tarawneh R, Holtzman DM Biomarkers in translational research of Alzheimer's Disease NEUROPHARMACOLOGY. 2010 SEP-OCT; 59 (4-5): 310-322	0	0	40	134
1164	26129 Hands SL, Wyttenbach A Neurotoxic protein oligomerisation associated with polyglutamine diseases ACTA NEUROPATHOLOGICA. 2010 OCT; 120 (4): 419-437	0	0	40	188
1165	26428 Chiu CT, Chuang DM Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders PHARMACOLOGY & THERAPEUTICS. 2010 NOV; 128 (2): 281-304	0	0	40	474
1166	26446 Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck GW, et al. Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model MOLECULAR NEURODEGENERATION. 2010 NOV 4; 5: Art. No. 47	0	0	40	50
1167	26712 Wadsworth JDF, Collinge J Molecular pathology of human prion disease ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 69-77	0	1	40	139
1168	27016 Pul R, Dodel R, Stangel M Antibody-based therapy in Alzheimer's disease EXPERT OPINION ON BIOLOGICAL THERAPY. 2011 MAR; 11 (3): 343-357	0	0	40	169
1169	3106 Trojanowski JQ, FUNG KM, RORKE LB, TOHYAMA T, YACHNIS AT, et al. IN-VIVO AND IN-VITRO MODELS OF MEDULLOBLASTOMAS AND OTHER PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS OF CHILDHOOD MOLECULAR AND CHEMICAL NEUROPATHOLOGY. 1994 FEB-APR; 21 (2-3): 219-239	30	30	39	83
1170	4107 BAUM L, SEGER R, WOODGETT JR, KAWABATA S, MARUYAMA K, et al. OVEREXPRESSED TAU-PROTEIN IN CULTURED-CELLS IS PHOSPHORYLATED WITHOUT FORMATION OF PHF - IMPLICATION OF PHOSPHOPROTEIN PHOSPHATASE INVOLVEMENT MOLECULAR BRAIN RESEARCH. 1995 DEC 1; 34 (1): 1-17	36	43	39	80
#	Date / Author / Journal	LCS	GCS	LCR	CR
1171	4489 BueeScherrer V, Condamines O, MourtonGilles C, Jakes R, Goedert M, et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease MOLECULAR BRAIN RESEARCH. 1996 JUL; 39 (1-2): 79-88	81	96	39	56
1172	4715 Ho CL, Liem RKH Intermediate filaments in the nervous system: Implications in cancer CANCER AND METASTASIS REVIEWS. 1996 DEC; 15 (4): 483-497	15	34	39	119
1173	4951 Goedert M The neurofibrillary pathology of Alzheimer's disease NEUROSCIENTIST. 1997 MAR; 3 (2): 131-141	6	8	39	64
1174	6466 Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G Tau interacts with src-family non-receptor tyrosine kinases JOURNAL OF CELL SCIENCE. 1998 NOV; 111: 3167-3177	92	140	39	95
1175	6925 Biernat J, Mandelkow EM The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains MOLECULAR BIOLOGY OF THE CELL. 1999 MAR; 10 (3): 727-740	33	52	39	77
1176	8567 Tolnay M, Spillantini MG, Rizzini C, Eccles D, Lowe J, et al. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: clinical and pathological features NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2000 AUG; 26 (4): 368-378	23	24	39	49
1177	8690 Barghorn S, Zheng-Fischhofer Q, Ackmann M, Biernat J, von Bergen M, et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias BIOCHEMISTRY. 2000 SEP 26; 39 (38): 11714-11721	104	119	39	59
1178	8799 Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease JOURNAL OF CELL SCIENCE. 2000 NOV; 113 (21): 3737-3745	103	130	39	65
1179	9014 Harrison PJ, Eastwood SL Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia HIPPOCAMPUS. 2001; 11 (5): 508-519	35	95	39	154
1180	9398 Goedert M Parkinson's disease and other alpha-synucleinopathies CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2001 APR; 39 (4): 308-312	35	41	39	56
#	Date / Author / Journal	LCS	GCS	LCR	CR
1181	9877 Rajagopalan S, Andersen JK Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? MECHANISMS OF AGEING AND DEVELOPMENT. 2001 SEP 30; 122 (14): 1499-1510	14	19	39	64
1182	9976 Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E beta-synuclein inhibits alpha-synuclein aggregation: A possible role as an anti-parkinsonian factor NEURON. 2001 OCT 25; 32 (2): 213-223	181	191	39	60
1183	10327 Chan SL, Furukawa K, Mattson MP Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease NEUROMOLECULAR MEDICINE. 2002; 2 (2): 167-196	8	34	39	241
1184	10493 Hand CK, Rouleau GA Familial amyotrophic lateral sclerosis MUSCLE & NERVE. 2002 FEB; 25 (2): 135-159	23	85	39	254
1185	10541 Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, et al. Immunocytochemical localization of synphilin-1, an alpha-synuclein- associated protein, in neurodegenerative disorders ACTA NEUROPATHOLOGICA. 2002 MAR; 103 (3): 209-214	41	46	39	42
1186	10616 Delobel P, Flament S, Hamdane M, Jakes R, Rousseau A, et al. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 MAR 15; 277 (11): 9199-9205	20	24	39	44
1187	11109 Utton MA, Connell J, Asuni AA, van Slegtenhorst M, Hutton M, et al. The slow axonal transport of the microtubule-associated protein tau and the transport rates of different Isoforms and mutants in cultured neurons JOURNAL OF NEUROSCIENCE. 2002 AUG 1; 22 (15): 6394-6400	25	29	39	60
1188	11810 Stein TD, Johnson JA Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 317-341	2	9	39	204
1189	11911 Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology ACTA NEUROPATHOLOGICA. 2003 FEB; 105 (2): 89-97	10	12	39	53
1190	12910 Shulman JM, Feany MB Genetic modifiers of tauopathy in Drosophila GENETICS. 2003 NOV; 165 (3): 1233-1242	56	84	39	89
#	Date / Author / Journal	LCS	GCS	LCR	CR
1191	13223 Neumann M, Kretzschmar HA Pathology and biochemistry of frontotemporal dementias NERVENHEILKUNDE. 2004; 23 (2): 73-79	1	1	39	52
1192	13929 Frasier M, Wolozin B Following the leader: fibrillization of alpha-synuclein and tau - Commentary EXPERIMENTAL NEUROLOGY. 2004 JUN; 187 (2): 235-239	8	9	39	47
1193	14389 Uversky VN Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 225-241	19	58	39	172
1194	14438 Stoppini M, Andreola A, Foresti G, Bellotti V Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing PHARMACOLOGICAL RESEARCH. 2004 OCT; 50 (4): 419-431	3	8	39	102
1195	15229 Maguire-Zeiss KA, Short DW, Federoff HJ Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 18-23	22	3	39	66
1196	15578 Smith WW, Margolis RL, Li XJ, Troncoso JC, Lee MK, et al. alpha-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells JOURNAL OF NEUROSCIENCE. 2005 JUN 8; 25 (23): 5544-5552	65	72	39	53
1197	15596 Liu CW, Giasson BI, Lewis KA, Lee VM, DeMartino GN, et al. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation - Implications for pathogenesis of Parkinson disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 17; 280 (24): 22670-22678	58	66	39	55
1198	15606 Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, et al. Forcing nonamyloidogenic beta-synuclein to fibrillate BIOCHEMISTRY. 2005 JUN 28; 44 (25): 9096-9107	21	37	39	82
1199	15664 Dinoto L, Deture MA, Purich DL Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 156-163	1	4	39	65
1200	16080 Reynolds MR, Berry RW, Binder LI Site-specific nitration differentially influences tau assembly in vitro BIOCHEMISTRY. 2005 OCT 25; 44 (42): 13997-14009	18	28	39	83

Date / Author / Journal

1101

Neurofilament metabolism in sporadic amyotrophic lateral sclerosis

JOURNAL OF THE NEUROLOGICAL SCIENCES. 1999 OCT 31; 169 (1-2): 170-177

119

1102

8182 Yasuda M, Takamatsu J, D'Souza I, Crowther RA, Kawamata T, et al.

A novel mutation at position+12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)

ANNALS OF NEUROLOGY. 2000 APR; 47 (4): 422-429

1103

8365 Crowther RA, Goedert M

Abnormal tau-containing filaments in neurodegenerative diseases

JOURNAL OF STRUCTURAL BIOLOGY. 2000 JUN; 130 (2-3): 271-279

1104

8633 Galvin JE, Nakamura M, McIntosh TK, Saatman KE, Sampathu D, et al.

Neurofilament-rich intraneuronal inclusions exacerbate neurodegenerative sequelae of brain trauma in NFH/LacZ transgenic mice

EXPERIMENTAL NEUROLOGY. 2000 SEP; 165 (1): 77-89

1105

8876 Sanchez I, Hassinger L, Sihag RK, Cleveland DW, Mohan P, et al.

Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: Selective role of site-specific phosphorylation

JOURNAL OF CELL BIOLOGY. 2000 NOV 27; 151 (5): 1013-1024

1106

8884 Bajaj NPS

Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS. 2000 DEC; 1 (5): 319-327

109

1107

9754 Blennow K, Vanmechelen E, Hampel H

CSF total tau, a beta 42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

MOLECULAR NEUROBIOLOGY. 2001 AUG-DEC; 24 (1-3): 87-97

1108

10185 von Bergen M, Barghorn S, Li L, Marx A, Biernat J, et al.

Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 DEC 21; 276 (51): 48165-48174

109

1109

10520 Cohlberg JA, Li J, Uversky VN, Fink AL

Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro

BIOCHEMISTRY. 2002 FEB 5; 41 (5): 1502-1511

102

1110

11217 Zhu XW, Lee HG, Raina AK, Perry G, Smith MA

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 270-281

120

143

Date / Author / Journal

LCS

GCS

LCR

1111

11251 Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, et al.

NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC)

ACTA NEUROPATHOLOGICA. 2002 OCT; 104 (4): 333-341

1112

11443 Biernat J, Wu YZ, Timm T, Zheng-Fischhofer QY, Mandelkow E, et al.

Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity

MOLECULAR BIOLOGY OF THE CELL. 2002 NOV; 13 (11): 4013-4028

100

1113

11619 Barghorn S, Mandelkow E

Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

BIOCHEMISTRY. 2002 DEC 17; 41 (50): 14885-14896

1114

12088 Munishkina LA, Phelan C, Uversky VN, Fink AL

Conformational behavior and aggregation of alpha-synuclein in organic solvents: Modeling the effects of membranes

BIOCHEMISTRY. 2003 MAR 11; 42 (9): 2720-2730

107

1115

12896 Delacourte A, Sergeant N, Buee L

In vitro models of age-related neurodegenerative disorders

EXPERIMENTAL GERONTOLOGY. 2003 NOV-DEC; 38 (11-12): 1309-1317

1116

12929 Ninkina N, Papachroni K, Robertson DC, Schmidt O, Delaney L, et al.

Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene

MOLECULAR AND CELLULAR BIOLOGY. 2003 NOV; 23 (22): 8233-8245

1117

13069 Rao MV, Campbell J, Yuan AD, Kumar A, Gotow T, et al.

The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate

JOURNAL OF CELL BIOLOGY. 2003 DEC 8; 163 (5): 1021-1031

1118

13187 Windisch M, Hutter-Paier B, Schreiner E, Wronski R

beta-synuclein-derived peptides with neuroprotective activity - An alternative treatment of neurodegenerative disorders?

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (1): 155-165

1119

14121 Nakashima H, Ishihara T, Yokota O, Terada S, Trojanowski JQ, et al.

Effects of alpha-tocopherol on an animal model of tauopathies

FREE RADICAL BIOLOGY AND MEDICINE. 2004 JUL 15; 37 (2): 176-186

1120

14271 Albani D, Peverelli E, Rametta R, Batelli S, Veschini L, et al.

Protective effect of TAT-delivered alpha-synuclein: relevance of the C- terminal domain and involvement of HSP70

FASEB JOURNAL. 2004 SEP; 18 (12): 1713-+

Date / Author / Journal

LCS

GCS

LCR

1121

14384 von Coelln R, Dawson VL, Dawson TM

Parkin-associated Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 175-184

1122

14684 Ross CA, Pickart CM

The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases

TRENDS IN CELL BIOLOGY. 2004 DEC; 14 (12): 703-711

103

1123

14721 Morris HR

Genetics of Parkinson's disease

ANNALS OF MEDICINE. 2005; 37 (2): 86-96

101

1124

14950 Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, et al.

Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress

HUMAN MOLECULAR GENETICS. 2005 JAN 1; 14 (1): 71-84

1125

14957 von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E

Tau aggregation is driven by a transition from random coil to beta sheet structure

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 158-166

1126

15058 Mikolaenko I, Pletnikova O, Kawas CH, O'Brien R, Resnick SM, et al.

Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 156-162

1127

15216 Liu Q, Smith MA, Avila J, DeBernardis J, Kansal M, et al.

Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations

FREE RADICAL BIOLOGY AND MEDICINE. 2005 MAR 15; 38 (6): 746-754

1128

15366 Braak H, Rub U, Steur ENHJ, Del Tredici K, de Vos RAI

Cognitive status correlates with neuropathologic stage in Parkinson disease

NEUROLOGY. 2005 APR 26; 64 (8): 1404-1410

123

1129

17260 Vartiainen S, Pehkonen P, Lakso M, Nass R, Wong G

Identification of gene expression changes in transgenic C-elegans overexpressing human alpha-synuclein

NEUROBIOLOGY OF DISEASE. 2006 JUN; 22 (3): 477-486

1130

17392 Kubo SI, Hattori N, Mizuno Y

Recessive Parkinson's disease

MOVEMENT DISORDERS. 2006 JUL; 21 (7): 885-893

126

Date / Author / Journal

LCS

GCS

LCR

1131

17563 Fleming SM, Chesselet MF

Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism

BEHAVIOURAL PHARMACOLOGY. 2006 SEP; 17 (5-6): 383-391

1132

17714 Lin H, Schlaepfer WW

Role of neurofilament aggregation in motor neuron disease

ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 399-406

1133

17874 Masters CL, Beyreuther K

Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A beta amyloid pathway

BRAIN. 2006 NOV; 129: 2823-2839

194

1134

18051 Braak H, Bohl JR, Muller CM, Rub U, de Vos RAI, et al.

Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered

MOVEMENT DISORDERS. 2006 DEC; 21 (12): 2042-2051

111

1135

18174 Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D

Treatment of dementia in Parkinsonian syndromes with cholinesterase inhibitors

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007; 23 (6): 351-367

176

1136

18241 Rankin CA, Sun Q, Gamblin TC

Tau phosphorylation by GSK-3 beta promotes tangle-like filament morphology

MOLECULAR NEURODEGENERATION. 2007; 2: Art. No. 12

1137

18289 Farkas O, Povlishock JT

Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 43-59

1138

18424 Chu YP, Kordower JH

Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

NEUROBIOLOGY OF DISEASE. 2007 JAN; 25 (1): 134-149

1139

18850 Shaw LM, Korecka M, Clark CM, Lee VMY, Trojanowski JQ

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

NATURE REVIEWS DRUG DISCOVERY. 2007 APR; 6 (4): 295-303

1140

18858 Kuhn M, Haebig K, Bonin M, Ninkina N, Buchman VL, et al.

Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein

NEUROGENETICS. 2007 APR; 8 (2): 71-81

Date / Author / Journal

LCS

GCS

LCR

1141

19411 Ferman TJ, Boeve BF

Dementia with Lewy bodies

NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 741-+

191

1142

19500 Rademakers R, Hutton M

The genetics of frontotemporal lobar degeneration

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2007 SEP; 7 (5): 434-442

1143

20924 Matus S, Lisbona F, Torres M, Leon C, Thielen P, et al.

The stress rheostat: An interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration

CURRENT MOLECULAR MEDICINE. 2008 MAY; 8 (3): 157-172

173

1144

20939 Lim J, Balastik M, Lee TH, Nakamura K, Liou YC, et al.

Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy

JOURNAL OF CLINICAL INVESTIGATION. 2008 MAY; 118 (5): 1877-1889

1145

21256 Moore DJ, Dawson TM

Value of genetic models in understanding the cause and mechanisms of Parkinson's disease

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2008 JUL; 8 (4): 288-296

1146

21688 Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, et al.

Direct quantification of CSF alpha-synuclein by ELISA and first cross- sectional study in patients with neurodegeneration

EXPERIMENTAL NEUROLOGY. 2008 OCT; 213 (2): 315-325

1147

21934 Luk KC, Mills IP, Trojanowski JQ, Lee VMY

Interactions between Hsp70 and the Hydrophobic Core of alpha-Synuclein Inhibit Fibril Assembly

BIOCHEMISTRY. 2008 NOV 25; 47 (47): 12614-12625

1148

22420 Kalinderi K, Fidani L, Bostantjopoulou S

From 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome

PARKINSONISM & RELATED DISORDERS. 2009 JAN; 15 (1): 2-5

1149

22578 Wijesekera LC, Leigh PN

Amyotrophic lateral sclerosis

ORPHANET JOURNAL OF RARE DISEASES. 2009 FEB 3; 4: Art. No. 3

299

1150

22804 Nakamura T, Lipton SA

Cell death: protein misfolding and neurodegenerative diseases

APOPTOSIS. 2009 APR; 14 (4): 455-468

174

Date / Author / Journal

LCS

GCS

LCR

1151

23855 Su XM, Federoff HJ, Maguire-Zeiss KA

Mutant alpha-Synuclein Overexpression Mediates Early Proinflammatory Activity

NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 238-254

1152

24093 Pirkevi C, Lesage S, Brice A, Basak AN

From Genes to Proteins in Mendelian Parkinson's Disease: An Overview

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY. 2009 DEC; 292 (12): 1893-1901

110

1153

24468 Dawson TM, Dawson VL

The Role of Parkin in Familial and Sporadic Parkinson's Disease

MOVEMENT DISORDERS. 2010; 25 (3): S32-S39

1154

24651 Szaro BG, Strong MJ

Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease

TRENDS IN NEUROSCIENCES. 2010 JAN; 33 (1): 27-37

109

1155

24682 Waxman EA, Emmer KL, Giasson BI

Residue Glu83 plays a major role in negatively regulating alpha- synuclein amyloid formation

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010 JAN 15; 391 (3): 1415-1420

1156

24747 Rozga M, Bal W

The Cu(II)/A beta/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity

CHEMICAL RESEARCH IN TOXICOLOGY. 2010 FEB; 23 (2): 298-308

164

1157

24936 Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, et al.

Novel therapeutics for Alzheimer's disease: An update

CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 MAR; 13 (2): 235-246

166

1158

25126 Pienaar IS, Dexter DT, Burkhard PR

Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis

EXPERT REVIEW OF PROTEOMICS. 2010 APR; 7 (2): 205-226

212

1159

25185 Murray LM, Talbot K, Gillingwater TH

Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 133-156

199

1160

25381 Di Giovanni S, Eleuteri S, Paleologou KE, Yin GW, Zweckstetter M, et al.

Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of alpha-Synuclein and beta-Amyloid and Protect against Amyloid-induced Toxicity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 MAY 14; 285 (20): 14941-14954

Date / Author / Journal

LCS

GCS

LCR

1161

25639 Jiang ML, Porat-Shliom Y, Pei Z, Cheng Y, Xiang L, et al.

Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism

JOURNAL OF NEUROCHEMISTRY. 2010 JUL; 114 (2): 419-429

1162

25752 Wang YP, Garg S, Mandelkow EM, Mandelkow E

Proteolytic processing of tau

BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 955-961

1163

26047 Tarawneh R, Holtzman DM

Biomarkers in translational research of Alzheimer's Disease

NEUROPHARMACOLOGY. 2010 SEP-OCT; 59 (4-5): 310-322

134

1164

26129 Hands SL, Wyttenbach A

Neurotoxic protein oligomerisation associated with polyglutamine diseases

ACTA NEUROPATHOLOGICA. 2010 OCT; 120 (4): 419-437

188

1165

26428 Chiu CT, Chuang DM

Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders

PHARMACOLOGY & THERAPEUTICS. 2010 NOV; 128 (2): 281-304

474

1166

26446 Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck GW, et al.

MOLECULAR NEURODEGENERATION. 2010 NOV 4; 5: Art. No. 47

1167

26712 Wadsworth JDF, Collinge J

Molecular pathology of human prion disease

ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 69-77

139

1168

27016 Pul R, Dodel R, Stangel M

Antibody-based therapy in Alzheimer's disease

EXPERT OPINION ON BIOLOGICAL THERAPY. 2011 MAR; 11 (3): 343-357

169

1169

3106 Trojanowski JQ, FUNG KM, RORKE LB, TOHYAMA T, YACHNIS AT, et al.

IN-VIVO AND IN-VITRO MODELS OF MEDULLOBLASTOMAS AND OTHER PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS OF CHILDHOOD

MOLECULAR AND CHEMICAL NEUROPATHOLOGY. 1994 FEB-APR; 21 (2-3): 219-239

1170

4107 BAUM L, SEGER R, WOODGETT JR, KAWABATA S, MARUYAMA K, et al.

OVEREXPRESSED TAU-PROTEIN IN CULTURED-CELLS IS PHOSPHORYLATED WITHOUT FORMATION OF PHF - IMPLICATION OF PHOSPHOPROTEIN PHOSPHATASE INVOLVEMENT

MOLECULAR BRAIN RESEARCH. 1995 DEC 1; 34 (1): 1-17

Date / Author / Journal

LCS

GCS

LCR

1171

4489 BueeScherrer V, Condamines O, MourtonGilles C, Jakes R, Goedert M, et al.

AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease

MOLECULAR BRAIN RESEARCH. 1996 JUL; 39 (1-2): 79-88

1172

4715 Ho CL, Liem RKH

Intermediate filaments in the nervous system: Implications in cancer

CANCER AND METASTASIS REVIEWS. 1996 DEC; 15 (4): 483-497

119

1173

4951 Goedert M

The neurofibrillary pathology of Alzheimer's disease

NEUROSCIENTIST. 1997 MAR; 3 (2): 131-141

1174

6466 Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G

Tau interacts with src-family non-receptor tyrosine kinases

JOURNAL OF CELL SCIENCE. 1998 NOV; 111: 3167-3177

140

1175

6925 Biernat J, Mandelkow EM

The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains

MOLECULAR BIOLOGY OF THE CELL. 1999 MAR; 10 (3): 727-740

1176

8567 Tolnay M, Spillantini MG, Rizzini C, Eccles D, Lowe J, et al.

A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: clinical and pathological features

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2000 AUG; 26 (4): 368-378

1177

8690 Barghorn S, Zheng-Fischhofer Q, Ackmann M, Biernat J, von Bergen M, et al.

Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias

BIOCHEMISTRY. 2000 SEP 26; 39 (38): 11714-11721

104

119

1178

8799 Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, et al.

C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease

JOURNAL OF CELL SCIENCE. 2000 NOV; 113 (21): 3737-3745

103

130

1179

9014 Harrison PJ, Eastwood SL

Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

HIPPOCAMPUS. 2001; 11 (5): 508-519

154

1180

9398 Goedert M

Parkinson's disease and other alpha-synucleinopathies

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2001 APR; 39 (4): 308-312

Date / Author / Journal

LCS

GCS

LCR

1181

9877 Rajagopalan S, Andersen JK

Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?

MECHANISMS OF AGEING AND DEVELOPMENT. 2001 SEP 30; 122 (14): 1499-1510

1182

9976 Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E

beta-synuclein inhibits alpha-synuclein aggregation: A possible role as an anti-parkinsonian factor

NEURON. 2001 OCT 25; 32 (2): 213-223

181

191

1183

10327 Chan SL, Furukawa K, Mattson MP

Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease

NEUROMOLECULAR MEDICINE. 2002; 2 (2): 167-196

241

1184

10493 Hand CK, Rouleau GA

Familial amyotrophic lateral sclerosis

MUSCLE & NERVE. 2002 FEB; 25 (2): 135-159

254

1185

10541 Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, et al.

Immunocytochemical localization of synphilin-1, an alpha-synuclein- associated protein, in neurodegenerative disorders

ACTA NEUROPATHOLOGICA. 2002 MAR; 103 (3): 209-214

1186

10616 Delobel P, Flament S, Hamdane M, Jakes R, Rousseau A, et al.

Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 MAR 15; 277 (11): 9199-9205

1187

11109 Utton MA, Connell J, Asuni AA, van Slegtenhorst M, Hutton M, et al.

The slow axonal transport of the microtubule-associated protein tau and the transport rates of different Isoforms and mutants in cultured neurons

JOURNAL OF NEUROSCIENCE. 2002 AUG 1; 22 (15): 6394-6400

1188

11810 Stein TD, Johnson JA

Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity

REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 317-341

204

1189

11911 Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A

Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology

ACTA NEUROPATHOLOGICA. 2003 FEB; 105 (2): 89-97

1190

12910 Shulman JM, Feany MB

Genetic modifiers of tauopathy in Drosophila

GENETICS. 2003 NOV; 165 (3): 1233-1242

Date / Author / Journal

LCS

GCS

LCR

1191

13223 Neumann M, Kretzschmar HA

Pathology and biochemistry of frontotemporal dementias

NERVENHEILKUNDE. 2004; 23 (2): 73-79

1192

13929 Frasier M, Wolozin B

Following the leader: fibrillization of alpha-synuclein and tau - Commentary

EXPERIMENTAL NEUROLOGY. 2004 JUN; 187 (2): 235-239

1193

14389 Uversky VN

Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 225-241

172

1194

14438 Stoppini M, Andreola A, Foresti G, Bellotti V

Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing

PHARMACOLOGICAL RESEARCH. 2004 OCT; 50 (4): 419-431

102

1195

15229 Maguire-Zeiss KA, Short DW, Federoff HJ

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 18-23

1196

15578 Smith WW, Margolis RL, Li XJ, Troncoso JC, Lee MK, et al.

alpha-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells

JOURNAL OF NEUROSCIENCE. 2005 JUN 8; 25 (23): 5544-5552

1197

15596 Liu CW, Giasson BI, Lewis KA, Lee VM, DeMartino GN, et al.

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation - Implications for pathogenesis of Parkinson disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 17; 280 (24): 22670-22678

1198

15606 Yamin G, Munishkina LA, Karymov MA, Lyubchenko YL, Uversky VN, et al.

Forcing nonamyloidogenic beta-synuclein to fibrillate

BIOCHEMISTRY. 2005 JUN 28; 44 (25): 9096-9107

1199

15664 Dinoto L, Deture MA, Purich DL

Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein

MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 156-163

1200

16080 Reynolds MR, Berry RW, Binder LI

Site-specific nitration differentially influences tau assembly in vitro

BIOCHEMISTRY. 2005 OCT 25; 44 (42): 13997-14009

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records